Results 11 to 20 of about 24,567 (257)

Safety evaluation of the food enzyme glucan 1,4‐α‐glucosidase from Aspergillus niger

open access: yesEFSA Journal, 2022
The food enzyme glucan 1,4‐α‐glucosidase (4‐α‐d‐glucan glucohydrolase, EC 3.2.1.3) is produced with a non‐genetically modified strain of Aspergillus niger by Beijing Shifa Technology & Trade Co., Ltd.
EFSA Panel on Food Contact Materials, Enzymes and Processing Aids (CEP)   +22 more
doaj   +1 more source

Safety evaluation of the food enzyme α‐amylase from the non‐genetically modified Bacillus licheniformis strain T74

open access: yesEFSA Journal, 2023
The food enzyme α‐amylase (4‐α‐D‐glucan glucanohydrolase; EC 3.2.1.1) is produced with the non‐genetically modified microorganism Bacillus licheniformis strain T74 by Novozymes A/S.
EFSA Panel on Food Contact Materials, Enzymes and Processing Aids (CEP)   +25 more
doaj   +1 more source

Environmental risk assessment of genetically modified plants - concepts and controversies [PDF]

open access: yes, 2011
Background and purpose: In Europe, the EU Directive 2001/18/EC lays out the main provisions of environmental risk assessment (ERA) of genetically modified (GM) organisms that are interpreted very differently by different stakeholders. The purpose of this
A Hilbeck   +57 more
core   +1 more source

Safety evaluation of the food enzyme α‐amylase from the non‐genetically modified Bacillus amyloliquefaciens strain NZYM‐WR

open access: yesEFSA Journal, 2023
The food enzyme α‐amylase (4‐α‐d‐glucan glucanohydrolase; EC 3.2.1.1) is produced with the non‐genetically modified Bacillus amyloliquefaciens strain NZYM‐WR by Novozymes A/S.
EFSA Panel on Food Contact Materials, Enzymes and Processing Aids (CEP)   +24 more
doaj   +1 more source

Societal Costs of Late Blight in Potato and Prospects of Durable Resistance Through Cisgenic Modification [PDF]

open access: yes, 2008
In the European Union almost 6 Mha of potatoes are grown representing a value of close to ¿6,000,000,000. Late blight caused by Phytophthora infestans causes annual losses (costs of control and damage) estimated at more than ¿1,000,000,000.
Boonekamp, P.M.   +7 more
core   +2 more sources

Safety evaluation of the food enzyme endo‐polygalacturonase from the non‐genetically modified Aspergillus tubingensis strain MUCL 55013

open access: yesEFSA Journal, 2023
The food enzyme endo‐polygalacturonase ((1→4)‐α‐D‐galacturonan glycanohydrolase (endo‐cleaving); EC 3.2.1.15)) is produced with the non‐genetically modified Aspergillus tubingensis strain MUCL 55013 by Soufflet Biotechnologies.
EFSA Panel on Food Contact Materials, Enzymes and Processing Aids (CEP)   +26 more
doaj   +1 more source

Potential benefits and risks of clinical xenotransplantation [PDF]

open access: yes, 2012
The transplantation of organs and cells from pigs into humans could overcome the critical and continuing problem of the lack of availability of deceased human organs and cells for clinical transplantation.
Ayares, D, Cooper, DKC
core   +2 more sources

Public understanding of science and common sense: Social representations of the human microbiome among the expert and non-expert public [PDF]

open access: yes, 2020
The aim of this investigation is to examine the structure and the content of different social groups’ representations of the human microbiome. We employed a non-probabilistic sample comprising two groups of participants.
Fasanelli, Roberto, Galli, Ida
core   +1 more source

A shotgun metagenomics approach to detect and characterize unauthorized genetically modified microorganisms in microbial fermentation products

open access: yesFood Chemistry: Molecular Sciences, 2021
The presence of a genetically modified microorganism (GMM) or its DNA, often harboring antimicrobial resistance (AMR) genes, in microbial fermentation products on the market is prohibited by European regulations.
Florence E. Buytaers   +9 more
doaj   +1 more source

Utilization of microorganism on the development of halal food based on biotechnology

open access: yesJournal of Halal Product and Research, 2019
Biotechnology has rapidly developed until now. The use of biotechnology was very extensive for human needs, including the food industry. Some biotechnological processes, both conventional   modern, were inseparable from the use of microorganisms.
Hayyun Durrotul Faridah   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy